Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
CELLAVISION AB

Industry News

Image: The VITROS 5600 integrated system (Photo courtesy of Ortho Clinical Diagnostics).

Ortho Clinical Diagnostics and EKF Diagnostics Collaborate for Assay

Ortho Clinical Diagnostics and EKF Diagnostics have entered into an agreement that allows Ortho customers to access the Beta-Hydroxybutyrate (BHB) assay, an important marker used in conjunction with clinical findings and other lab tests for the diagnosis and management of ketoacidosis and its main causative factor, diabetic ketoacidosis (DKA). The fully automated assay is now available for use on Ortho's VITROS 4600 chemistry system and the VITROS 5600 integrated system. More...
17 Oct 2017
Image: BioVendor has acquired 100% of the shares of DIAsourceImmunoAssays SA (Photo courtesy of iStock).

BioVendor Acquires All Shares of DIAsource ImmunoAssays SA

BioVendor - Laboratornímedicínaa.s., an international diagnostics holding, has acquired 100% of the shares of DIAsourceImmunoAssays SA from Anteo Diagnostics, which had acquired DIAsource in January 2016. More...
16 Oct 2017
ELITech Group
Image: Siemens Healthineers and HORIBA Medical have entered into a long-term agreement to create new hematology solutions (Photo courtesy of iStock).

Siemens Healthineers Enters Agreement with HORIBA Medical

Siemens Healthineers and HORIBA Medical have entered into a long-term agreement to bring new and innovative hematology solutions to the market globally. More...
16 Oct 2017
Image: Abbott has closed the acquisition of Alere (Photo courtesy of iStock).

Abbott Closes Acquisition of Alere

Abbott has closed the acquisition of Alere, Inc., following the receipt of all regulatory clearances required for the closing. More...
11 Oct 2017
Image: Companies with laboratory-developed tests are attracting increasing investor interest and raised over USD 2 billion between January and August 2017 (Photo courtesy of iStock).

Companies with Lab-Developed Tests Raise USD 2 Billion

Companies with laboratory-developed tests (LTDs), tests performed by laboratories owned by IVD companies and others, are attracting increasing investor interest and raised over USD 2 billion between January and August 2017. These are the latest findings of Kalorama Information, an independent medical market research firm. More...
11 Oct 2017
Image: The global point-of-care (POC) HbA1C testing market is projected to grow by almost 9% between 2017-2021 (Photo courtesy of iStock).

Top Trends Impacting Global POC Testing Market

The global point-of-care (POC) HbA1C testing market is projected to grow at a CAGR of almost 9% from 2017-2021, driven mainly by the unhealthy lifestyles of people resulting in increased prevalence of diabetes and obesity, easy patient accessibility to POC tests and faster availability of results as compared to conventional laboratory testing procedures. More...
09 Oct 2017
Image: The Endura MD mass spectrometer (Photo courtesy of Thermo Fisher Scientific).

Thermo LC-MS Solutions Receive ANVISA Registration in Brazil

Thermo Fisher Scientific’s liquid chromatography mass spectrometry (LC-MS) in vitro diagnostic (IVD) systems, which enable the quantitation of analytes in complex matrices, have received registration by Brazil’s National Health Surveillance Agency (ANVISA), allowing clinical laboratories in the country to now screen and quantify drugs efficiently. More...
03 Oct 2017


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2017 Globetech Media. All rights reserved.